Prescription patterns of P2Y12 inhibitors following revascularization in the United States: 2013-2018

• প্রধান লেখক: Arun Kumar (লেখক), Pamela L. Lutsey (লেখক), Wendy L. St. Peter (লেখক), Jon C. Schommer (লেখক), Jeremy R. Van't Hof (লেখক), Abhijeet Rajpurohit (লেখক), Joel F. Farley (লেখক)
• বিন্যাস: গ্রন্থ
• প্রকাশিত: Wiley, 2023-10-01T00:00:00Z.
• বিষয়গুলি: article
• অনলাইন ব্যবহার করুন: Connect to this object online.

Abstract P2Y12 inhibitors (i.e., clopidogrel, prasugrel, or ticagrelor) are effective at reducing adverse cardiovascular outcomes post‐revascularization in coronary artery disease (CAD). However, the choice of a specific P2Y12 inhibitor may vary according to the patient's characteristics, and t...